Sunday, March 25, 2018


Robert Martin with Keira Ely
Age Range: 8 - 12 years
Grade Level: 4 - 6
Hardcover: 32 pages
Publisher: DreamChaser Publishing LLC (August 1, 2017)
Language: English
ISBN-10: 0990831736
ISBN-13: 978-0990831730


Meet Clara, a five-year-old girl that is super positive and super happy. If something disappoints, she smiles it away. If something is wrong, she does her best to fix it.

Clara learns that she has brain cancer. Her treatment requires surgery, radiation, and chemotherapy. Like any child, she first resists the need for radiation treatment and years of having to take medicine. She asks questions, her way of making sure that this is the best way to fix it. She reluctantly agrees, and although she is afraid, she maintains her positive attitude.

Following the radiation treatment, Clara discovers that she has special powers that allow her to connect with animals in extraordinary ways she can tell what they are feeling inside, understand what they are saying and they can understand her.

Clara's journey takes her to the dog park, where her dog Maggie is frightened by Fang the bully; the zoo where the sea lion Fuzzy is embarrassed to be seen; and the Cheetahs' den where Dash seems very angry about something. Clara quickly recognizes that fear, embarrassment, and anger, are the same feelings she experienced with cancer and the cancer treatments. She responds to their plight with her winning attitude and special powers, helping them to overcome their negative feelings, making them happy once again.

All terminally ill victims need support from family and friends, as well as their own courage to remain positive and diligent. For children, it's even harder. The fear they have from not understanding anything that is happening to them only adds to their anxiety: "What is cancer? Why me? Did I do something wrong?"

SuperClara - A Young Girl's Story of Cancer, Bravery, and Courage, presents answers in a way that instills comfort to the child battling a terminal disease and at the same time provides a much-needed injection of courage.

SuperClara's story can also be an inspiration to anyone who is discouraged for any reason; it puts life's challenges and disappointments into perspective. It helps people of all age be more appreciative of their present circumstances.

The funds generated will be directed to the Bridge to a Cure Foundation. The mission of Bridge to a Cure is to provide funds to research life-sustaining-treatments for terminally ill victims. The expectation is that the research will not only consider current and prior clinical trials, but also drugs that are off patent, and many of the alternative treatments.

My Thoughts

This is one of the best books I have read for children and families dealing with cancer and specifically brain cancer.

Cancer is not easy for us adults to comprehend and it's often more difficult for children to understand.

It takes a tremendous amount of courage for those dealing with a terminal diagnosis as well as the family and friends that are supporting them during the process.

 To make it easier for children to understand there are engaging illustrations that show the process Clara went through.

This read describes diagnosis, treatments and its effects on the body. It is inspirational, motivational and has a positive message about attitudes in dealing with disease and the importance of encouragement and support.

While I received this book for an honest review, it is also personal to me having lost a family member to brain cancer.

Media coverage

To make the impact extend even further, proceeds from the book’s sales go to help fund the mission of Bridge to a Cure Foundation, a nonprofit dedicated to increasing the pace and success of pediatric research by unleashing resources already available today. For more information about the Mission and Vision of Bridge to a Cure and how Proceeds from Robert Martin’s book sales help fund the mission of the Bridge to a Cure Foundation, to increase the pace and success of pediatric research by unleashing resources already available today.

No comments:

Post a Comment